Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Detection of Recurrent Mutations by Pooled Targeted Next-Generation Sequencing in MDS Patients Prior to Treatment with Hypomethylating Agents or Stem Cell Transplantation

    ... treated with Vidaza® ( azacitidine ), Dacogen® ( decitabine ), or both azacitidine and decitabine. The 76 patients in Cohort 2 underwent a stem cell transplant ...

    Research Review last updated 05/02/2016 - 9:26am.

  2. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... or lymphoma chemotherapy or azacitidine or decitabine or tyrosine kinase inhibitor. Patients aged 18-70 years at ... at least one cycle of cytotoxic chemotherapy, azacitidine or decitabine. MDS patients must have < or = to 5% bone marrow ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  3. Acute Myeloid Leukemia (AML)

    ... able to tolerate toxic chemotherapy drugs. Drugs such as decitabine or azacitidine or hydroxyurea may be better tolerated by ...

    Topic section last updated 07/07/2016 - 3:15pm.

  4. Clofarabine in the treatment of myelodysplastic syndromes

    ... inhibitors, such as azacitidine and decitabine , are standard of care for patients with MDS who require ...

    Research Review last updated 05/02/2016 - 9:18am.

  5. Amer Zeidan, M.D.

    ... to the existing drugs (such as azacitidine and decitabine ) and are not candidates for stem cell transplantation. Studies ...

    Bio last updated 03/11/2016 - 1:41pm.

  6. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... stem cell transplant Prior azacitidine , decitabine , or midostaurin Patients with known impairment of ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  7. Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy from the European Leukemianet Low Risk MDS (EUMDS) Registry

    ... (such as Vidaza® [ azacitidine ] or Dacogen® [ decitabine ]), a granulocyte colony-stimulating factor, hydroxyurea, ...

    Research Review last updated 05/02/2016 - 9:27am.

  8. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... treatment with demethylating agents (azacytidine or decitabine , lenalidomide , etc) ALLOWED. Cohort B: Patients who ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  9. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... this study with the exception of lenalidomide , decitabine , azacitidine , imatinib mesylate, dasatinib, nilotinib ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  10. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    ... , or an adequate course of 5- azacitidine or decitabine must have been given within 3 months prior to start of ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.